Association between interstitial fibrosis/tubular atrophy (IFTA) on kidney biopsies and anti Ro60 antibody positivity in patients with lupus nephritis (LN)
- 16 April 2026
- journal article
- research article
- Published by SAGE Publications in Lupus
- Vol. 35 (8) , 810-817
Abstract
Background: Interstitial fibrosis and tubular atrophy (IFTA) are key predictors of renal outcomes in lupus nephritis (LN), but serologic markers that identify patients at higher risk for tubulointerstitial damage are poorly defined. Anti-Ro60 antibodies are associated with heightened systemic immune activation and worse renal outcomes in systemic lupus erythematosus, but their relationship to IFTA in LN is unknown. Methods: We performed a retrospective cohort study of adults with biopsy-confirmed LN at a single academic center. Clinical data, autoantibody profiles, and renal histopathology were abstracted from the medical record at or near the time of kidney biopsy. Ro60 status was determined by standard clinical immunoassays. IFTA severity was graded by a renal pathologist as none, mild, moderate, or severe. Ordinal logistic regression was used to evaluate the association between Ro60 positivity and IFTA severity. A multivariable proportional odds model included Ro60 positivity (primary exposure), Black race (the only variable with p < 0.05 in the univariable analysis), and ISN/RPS class IV LN (an a priori clinical risk factor for fibrosis). Sensitivity analyses included dichotomizing IFTA (absent/mild vs moderate/severe), excluding the single severe IFTA case, and restricting to Black patients. Results: Forty-one patients met the inclusion criteria; 16 (39%) were Ro60-positive, and 25 (61%) were Ro60-negative. Ro60-positive patients were more often Black and had lower C3 and C4 levels; the distribution of LN classes was similar between groups. In univariable analysis, Ro60 positivity was associated with higher odds of more severe IFTA (OR 3.05; 95% CI 0.86–11.5; p = 0.087), while Black race was strongly associated with worse IFTA (OR 7.82; 95% CI 1.02–93.12; p = 0.014). In the multivariable model limited to 29 complete cases, Ro60 positivity remained associated with higher IFTA severity (OR 2.76; 95% CI 0.77–13.04; p = 0.127), and Black race remained the strongest predictor (OR 8.06; 95% CI 0.92–275.61; p = 0.015); class IV LN was not significantly associated with IFTA (OR 1.90; 95% CI 0.37–13.24; p = 0.371). In a sensitivity analysis excluding the single patient with severe IFTA, the association between Ro60 positivity and IFTA strengthened (OR 5.25; p = 0.028), and Black race remained strongly associated with worse IFTA (OR 15.79; p = 0.005). Conclusions: In this biopsy-based LN cohort, Ro60 positivity was associated with a consistent trend toward more severe IFTA, with a statistically significant association in sensitivity analysis excluding one severe outlier case. Black race was the most robust predictor of IFTA severity, highlighting persistent racial disparities in LN-related kidney damage. These findings support the hypothesis that anti-Ro60 antibodies contribute to tubulointerstitial injury and suggest that Ro60 status may help identify LN patients at higher risk for chronic structural damage. Larger, prospective studies are needed to confirm these associations and clarify the prognostic role of Ro60 in LN.Keywords
This publication has 12 references indexed in Scilit:
- The implication of anti-Ro60 with or without anti-Ro52 antibody in patients with systemic lupus erythematosusRheumatology, 2024
- Combination of anti-SSA/Ro60 and anti-dsDNA serotype is predictive of belimumab renal response in patients with lupus nephritisLupus Science & Medicine, 2024
- Predicting kidney outcomes among Latin American patients with lupus nephritis: The prognostic value of interstitial fibrosis and tubular atrophy and tubulointerstitial inflammationLupus, 2023
- Anti‐dsDNA, anti‐nucleosome, anti‐C1q, and anti‐histone antibodies as markers of active lupus nephritis and systemic lupus erythematosus disease activityImmunity, Inflammation and Disease, 2021
- Interstitial inflammation and interstitial fibrosis and tubular atrophy predict renal survival in lupus nephritisClinical Kidney Journal, 2017
- End‐Stage Renal Disease in African Americans With Lupus Nephritis Is Associated With APOL1Arthritis & Rheumatology, 2013
- Tubulointerstitial lesions of patients with lupus nephritis classified by the 2003 International Society of Nephrology and Renal Pathology Society systemKidney International, 2010
- Classification of lupus nephritisCurrent Opinion in Nephrology and Hypertension, 2009
- The classification of glomerulonephritis in systemic lupus erythematosus revisitedKidney International, 2004
- Tubulointerstitial Disease in Lupus Nephritis: Relationship to Immune Deposits, Interstitial Inflammation, Glomerular Changes, Renal Function, and PrognosisNephron, 1986